Cargando…
Design, synthesis, and biological evaluation of novel androst-17β-amide structurally related compounds as dual 5α-reductase inhibitors and androgen receptor antagonists
Prostate cancer (PCa) is the second leading cause of death in men. Apart from androgen receptor, 5α-reductase has also been recognized as a potential target. In this study, a series of androst-17β-amide compounds have been designed and synthesized targeting both AR and 5α-reductase. Their anti-proli...
Autores principales: | Lao, Kejing, Xun, Guoliang, Gou, Xingchun, Xiang, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735293/ https://www.ncbi.nlm.nih.gov/pubmed/31469015 http://dx.doi.org/10.1080/14756366.2019.1654469 |
Ejemplares similares
-
5α-Androst-3-en-17β-yl acetate
por: Andrade, L. C. R., et al.
Publicado: (2009) -
11α,15α-Dihydroxyandrost-4-ene-3,17-dione
por: Shen, Yan-Bing, et al.
Publicado: (2011) -
16α,17α-Epoxy-17β-(1H-imidazol-1-yl)androst-4-en-3-one monohydrate
por: Anitha, A. G., et al.
Publicado: (2012) -
2′-Methylpyrazolo[4′,3′:16,17]androst-5-en-3β-ol
por: Zheng, Hu-ling, et al.
Publicado: (2009) -
Semi-rational engineering an aldo–keto reductase for stereocomplementary reduction of α-keto amide compounds
por: Bai, Ruixuan, et al.
Publicado: (2023)